Synox Therapeutics UK Limited – Trademark Portfolio

Entity Type: 98

Synox Therapeutics UK Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include YUQENA and YOJEMTU.

John Eccles House,

Robert Robinson Avenue Oxford OX4 4GP

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YOJEMTU
YOJEMTU
Registered 2025
YUQENA
YUQENA
Registered 2025

Trademark Classifications

Synox Therapeutics UK Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Synox Therapeutics UK Limited have?

Synox Therapeutics UK Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Synox Therapeutics UK Limited file in?

Synox Therapeutics UK Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Synox Therapeutics UK Limited's most well-known trademarks?

Synox Therapeutics UK Limited's registered trademark portfolio includes well-known marks such as YUQENA and YOJEMTU. These are among 2 currently registered trademarks in the portfolio.

What is Synox Therapeutics UK Limited's trademark registration success rate?

Synox Therapeutics UK Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.